Gene therapy’s next class of biotechs
And the innovative technologies they’re developing
It’s been a rough year for gene therapies in the clinic, but that hasn’t slowed momentum for the new class of biotechs working on next-generation technology for the modality’s challenges.
BioCentury’s analysis of 51 gene therapy companies founded within the past five years exposes an approaching shift in the technology landscape. ...